SEBREE TERRI B (President) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2023ACC: 0000899243-23-003725
Officer· President
Since Aug 2018
+24.37K
Net shares
Net buyer
$5.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
33.69K acquired · 9.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+33.69K
Price / share
—
Trade value
—
% of position
6.6%
1/31/2023
513.20K→546.89K
Common Stock
Direct
Shares
−9.32K
Price / share
$0.60
Trade value
$5.55K
% of position
1.7%
2/1/2023
546.89K→537.57K
Total
Net shares
+24.37K
Net value
-$5.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2023 | A · Award | +33.69K | — | — | 6.6% | 513.20K | 546.89K |
| Common Stock Direct | 2/1/2023 | F · Tax Withholding | −9.32K | $0.60 | $5.55K | 1.7% | 546.89K | 537.57K |
| Total | +24.37K | -$5.55K | ||||||
Derivative Transactions0
No derivative transactions reported